Your browser doesn't support javascript.
loading
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Hua, Y; Tang, L L; Fewel, M E; Keep, R F; Schallert, T; Muraszko, K M; Hoff, J T; Xi, G H.
Affiliation
  • Hua Y; Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan 48109-0532, USA.
Acta Neurochir Suppl ; 95: 403-6, 2005.
Article in En | MEDLINE | ID: mdl-16463890
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pipecolic Acids / Brain Edema / Brain Neoplasms / Glioma / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies Limits: Animals Language: En Journal: Acta Neurochir Suppl Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Austria
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pipecolic Acids / Brain Edema / Brain Neoplasms / Glioma / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies Limits: Animals Language: En Journal: Acta Neurochir Suppl Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Austria